OptimizeRx Corp(OPRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 6 at 4:20 PM ET (Korea 11/7 06:20)
Full metrics table
| Index | - | P/E | 37.24 | EPS (ttm) | 0.24 | Insider Own | 14.99% | Shs Outstand | 18.8M | Perf Week | -6.01% |
| Market Cap | 0.17B | Forward P/E | 8.39 | EPS next Y | 19.18% | Insider Trans | - | Shs Float | 16.0M | Perf Month | 4.53% |
| Enterprise Value | 0.16B | PEG | 13.32 | EPS next Q | 0.16 | Inst Own | 68.8% | Short Float | 6.74% | Perf Quarter | 27.7% |
| Income | 0.00B | P/S | 1.67 | EPS this Y | -16.57% | Inst Trans | -10.41% | Short Ratio | 6.01 | Perf Half Y | 36.02% |
| Sales | 0.10B | P/B | 1.26 | EPS next 5Y | 0.63% | ROA | 2.76% | Short Interest | 1.08M | Perf YTD | -28.55% |
| Book/sh | 6.96 | P/C | 6.85 | EPS past 3/5Y | - | ROE | 3.68% | 52W High | -55.24% ($19.57) | Perf Year | -53.75% |
| Cash/sh | 1.28 | P/FCF | 8.87 | Sales past 3/5Y | 20.56% 20.37% | ROIC | 3.09% | 52W Low | 92.95% ($4.54) | Perf 3Y | -10.52% |
| Dividend Est. | - | EV/EBITDA | 10.29 | EPS Y/Y TTM | 145.91% | Gross Margin | 68.88% | Volatility(W/M) | 6.5% 5.34% | Perf 5Y | -90.82% |
| Dividend TTM | - | EV/Sales | 1.63 | Sales Y/Y TTM | -5.82% | Oper. Margin | 11.45% | ATR (14) | 0.49 | Perf 10Y | 197.96% |
| Dividend Ex-Date | - | Quick Ratio | 5.58 | EPS Q/Q | -146.4% | Profit Margin | 4.66% | RSI (14) | 48.76 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.58 | Sales Q/Q | -29.77% | SMA20 | -2.49% ($8.98) | Beta | 1.16 | Target Price | $12.6 |
| Payout | - | Debt/Eq | 0.15 | Earnings | 2026/11/11 | SMA50 | 4.97% ($8.35) | Rel Volume | 1.13 | Prev Close | $8.67 |
| Employees | 133 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 44.01% 1.47% | SMA200 | 21.22% ($7.23) | Avg Volume(3M) | 0.18M | Price | $8.76 |
| IPO | 2005/5/18 | Option/Short | Yes/Yes | Trades | 2507 | Volume | 202,076 | Change | 1.04% |
💊 OptimizeRx is a digital healthcare technology company that connects pharmaceutical companies with medical practices. It operates a messaging platform within Electronic Health Records (EHR) and e-prescribing systems that delivers brand messages, treatment support, and out-of-pocket cost information to healthcare providers. The company focuses on enhancing the precision of pharmaceutical marketing through machine learning-based audience targeting.
Over the past 1 year, roughly in the middle
55% below its 1-year high.
Traded about as much as usual. That is 113% of its average volume.
Next earnings report: November 11
3 days to go.
OPRX earns at a steady pace
Of every $100 in sales, $11.45 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -16.6% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $3,724. Peers typically go for $4,441. It is about in line with its own 2-year average.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -90.8%. The S&P 500 did +57% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 68.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #28 of 41 in the industry
Based on market cap of $165M.
AMWL#25 American Well Corp $205M PER - 
SY#26 So-Young International Inc ADR $174M PER - 
DH#27 Definitive Healthcare Corp $167M PER - OPRX#28 OptimizeRx Corp $165M PER 37.2 
LFMD#29 LifeMD Inc $114M PER - 
FAQ
What kind of company is OPRX?
OPRX belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of OPRX?
The market cap of OPRX is approximately $165M, ranking 4,146 within its sector.
What is the P/E ratio of OPRX?
OPRX has a P/E ratio of approximately 37.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OPRX?
OPRX has recorded a 52-week high of $19.57 and a low of $4.54.
